Novel Therapeutic Advances in β-Thalassemia
Alexandros Makis(University Hospital of Ioannina), Eleftheria Hatzimichael(Thomas Jefferson University), Ioannis Papassotiriou(National and Kapodistrian University of Athens), Ersi Voskaridou(Laiko General Hospital of Athens)
Cited by 36
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Oxidative stress biomarkers responses to physical overtraining: Implications for diagnosis
|Free Radical Biology and Medicine|2007|305
Muscle damage, inflammatory, immune and performance responses to three football games in 1 week in competitive male players
|European Journal of Applied Physiology|2015|212
Sampling Time is Crucial for Measurement of Aerobic Exercise-Induced Oxidative Stress
|Medicine & Science in Sports & Exercise|2007|204
Physiological and performance adaptations of elite Greco-Roman wrestlers during a one-day tournament
|European Journal of Applied Physiology|2010|184